Last Updated: November 2, 2026
At-Home Ketamine Therapy in Arizona
Mindbloom offers guided at-home ketamine therapy throughout Arizona, serving residents in Phoenix, Tucson, Scottsdale, and communities statewide via telehealth. This guide covers how at-home ketamine therapy works, how it compares to in-clinic options, what Mindbloom's published outcomes data shows, and what to consider when choosing a provider in Arizona.

Key takeaways
- Arizona residents can start Mindbloom's guided at-home ketamine program entirely via telehealth — no in-person facility visits required, regardless of location in the state.
- In Mindbloom's 2022 peer-reviewed study of 1,247 clients using sublingual tablets, 89% reported improvement in depression or anxiety after four sessions.12
- Mindbloom is the only at-home ketamine provider offering both sublingual and subcutaneous administration, giving Arizona residents a dosing option unavailable through other telehealth programs.
- In Mindbloom's published safety data, serious adverse events occurred in fewer than 0.1% of participants, with a discontinuation rate due to side effects of just 0.4%.
- At-home ketamine therapy programs are approximately 60% more affordable per session than average in-clinic IV ketamine infusions.
Ketamine Therapy Options in Arizona: How They Compare
Arizona residents searching for ketamine therapy have several modality options, ranging from in-clinic infusions to telehealth-based care.
When evaluating treatment, you should understand each option on its own terms.
- IV ketamine infusions: Administered intravenously in a facility. Higher bioavailability doesn't by itself mean better outcomes. Sublingual ketamine absorbs at about 30% (Rolan et al., 2014) and IV at close to 100%, yet published depression response is comparable: 56.4% for Mindbloom clients by session 4 (Mathai 2024) vs. 53.6% for IV (McInnes 2022).1,13,14 Bioavailability is how much of a dose reaches the bloodstream, and doses are calibrated to each route. You typically need multiple in-person visits, which carries a higher per-session cost.
- IM (intramuscular) ketamine: Injected in a facility, requiring similar in-person monitoring and scheduling as IV treatments.
- Spravato (esketamine): An FDA-approved nasal spray for treatment-resistant depression. You must receive it in a certified facility with post-dose monitoring under the REMS program, and access often depends on insurance prior authorization.4
- At-home ketamine therapy: Providers like Mindbloom offer sublingual tablets or subcutaneous injectables administered in your home. You must have a peer treatment monitor, a friend or family member you choose, present, and your care is overseen by telehealth.
Mindbloom is also the only at-home provider offering subcutaneous administration alongside sublingual tablets. For published outcomes data comparing improvement rates, see the Mindbloom Outcomes section below.
| Modality | Setting | Administration | Monitoring | Approx. Cost Range in AZ | Statewide Availability |
|---|---|---|---|---|---|
| IV Ketamine | In-clinic | Intravenous | Medical staff | $400–$800+ per session | Limited to facility locations |
| IM Ketamine | In-clinic | Intramuscular | Medical staff | Varies by facility | Limited to facility locations |
| Spravato | Certified facility | Nasal spray | REMS protocol | Varies by insurance | Limited to certified facilities |
| Mindbloom | At-home | Sublingual / Subcutaneous | Peer treatment monitor | $165–$215 per session | Yes, via telehealth |
How Supervised At-Home Ketamine Programs Work in Arizona
Provider-directed at-home ketamine therapy is a full medical protocol delivered via telehealth, with defined intake, prescribing, session, and integration stages. The process involves defined intake, prescribing, session, and integration stages.
The journey begins with a medical screening and eligibility evaluation by a licensed physician or psychiatric specialist. If approved, your provider develops a diagnosis and treatment plan, prescribing ketamine at sub-anesthetic, therapeutic doses.
Sessions take place in your own home, providing a familiar environment that can support deeper therapeutic experiences. A peer treatment monitor must be present during every session, alongside your clinician's oversight of screening, dosing, and progress. Your Mindbloom guide walks them through the process and gives them the information and resources they need to feel comfortable in the role. They stay in a nearby room, checking in about every 15 minutes. Integration is the process of translating session insights into lasting behavioral and cognitive change through coaching, reflection, and community support.
Mindbloom has facilitated more than 900,000 ketamine therapy sessions as of October 2026. Programs are offered in series of 6, 12, or 18 sessions, with treatment frequency personalized based on your individual needs and goals. Each program includes:
- Provider consults: Ongoing medical oversight to assess progress and adjust dosing.
- Ketamine treatments: Choice of sublingual tablets or subcutaneous injectables.
- Guide coaching: 1:1 preparation and integration sessions, plus unlimited messaging. Every Mindbloom client works with a dedicated guide, a trained psychedelic integration specialist who helps them prepare for each session and turn what comes up into lasting change. Guides are part of a care team led by licensed clinicians, who handle evaluation, prescribing, and dosing, and guides share safety and progress updates with them.
- Integration Circles: Unlimited access to peer group support.
- Bloombox: A physical experiential toolkit with session essentials.
- Mindbloom App: Full-featured app-guided programs with custom soundscapes.
Mindbloom Outcomes: Published Results for Depression, Anxiety, and PTSD
Mindbloom's three peer-reviewed, real-world outcomes studies, two of sublingual tablets and one of subcutaneous injections, come from Mindbloom's own patient population and form the largest published evidence base in at-home ketamine therapy. Building on decades of research into ketamine's therapeutic applications, these studies used the Mindbloom protocol.
Many people report noticeable symptom improvement within hours or days of their first session. More durable and cumulative benefits typically develop over a series of treatments, supported by integration practices. Because study designs, patient populations, and outcome measures vary across modalities, direct comparisons require caution — but Mindbloom's published data shows depression improvement rates that meet or modestly exceed those in selected IV ketamine studies.5
- Depression and Anxiety: In the largest published study of at-home ketamine therapy, which followed 11,441 patients using sublingual tablets and assessed them with the PHQ-9 and GAD-7, the response rate was 56.4% for depression and 56.1% for anxiety (among 7,776 patients with a baseline anxiety score).1 These figures exceed those reported in selected SSRI antidepressant studies and meta-analyses of talk therapy.6,7 In Mindbloom's 2022 peer-reviewed study of 1,247 clients using sublingual tablets, 89% reported improvement in depression or anxiety after four sessions.12 With subcutaneous injections, by the end of the six-session course, depression response was 56.6% and remission 27.7% (81.8% clinically meaningful improvement), and anxiety response was 60.6% and remission 29.6% (80.0% clinically meaningful improvement).8
- PTSD: In Mindbloom's peer-reviewed study of clients using subcutaneous injections, assessed with the PCL-5, by the end of the six-session course, 84.6% saw clinically meaningful improvement, with a 76.7% response rate and 56.7% remission rate.8 Mindbloom is the only at-home provider with peer-reviewed PTSD outcomes.
- Sleep: In a real-world analysis of 13,963 adults with moderate-to-severe sleep disturbance, 76.8% of clients who completed treatment met criteria for sleep response.10
- Safety profile: Across studies, side effects were reported by about 4 to 5% of participants per check-in (sublingual tablets) and 2.8 to 3.2% of participants per check-in (subcutaneous injections). Serious adverse events occurred in fewer than 0.1% of participants, and the discontinuation rate due to adverse events was 0.4%.1,8
Individual results may vary.
Common Co-Occurring Conditions
While Mindbloom's core programs address depression, anxiety, and PTSD, many clients experience co-occurring conditions. Research is expanding across multiple mental health and behavioral health contexts. Ketamine has shown potential benefits for people who also struggle with OCD, chronic pain, postpartum depression, and nicotine cessation. Mindbloom does not diagnose or treat these as standalone conditions, but many people experience them alongside primary indications.
Safety Protocols for At-Home Ketamine Therapy
Safety in ketamine therapy is a function of medical supervision, thorough screening, and defined protocols rather than the physical treatment setting itself.1 Ketamine has been FDA-approved as an anesthetic since 1970 and is listed on the World Health Organization's Model List of Essential Medicines.2 Using it for mental health conditions represents off-label prescribing, which is a widespread and legally accepted medical practice accounting for about 21% of U.S. office-based prescriptions (Radley et al., 2006).3 Reputable programs build safety into every stage of care, from intake through post-session follow-up.
In-clinic ketamine care typically includes medical screening, vital sign monitoring during the infusion, a post-dose observation period, and on-site physician availability. You might prefer this setting if you require direct medical observation.
Reputable at-home ketamine care includes thorough medical screening, contraindication and medication interaction reviews, and provider-determined dosing. The FDA has warned that compounded ketamine can carry risks related to formulation variability, sedation, dissociation, blood pressure changes, and inadequate monitoring when care is not clinically structured.11 However, regulation alone does not remove risk; in ketamine care, safety depends on clinician screening, appropriate prescribing, reliable pharmacy sourcing, dose verification, and structured monitoring.
Mindbloom builds safety into its at-home model through several specific elements:
- Screening: Detailed medical history, contraindication, and medication interaction review.
- Dosing: Sub-anesthetic, provider-determined therapeutic doses tailored to the individual.
- Monitoring: A peer treatment monitoris required to be present during every session.
- Support: Access to guide coaching, medical consults, and clear escalation protocols, including an on-call clinician.
- Follow-up: Ongoing consults to assess progress and adjust treatment plans.
- Escalation: Defined care protocols for managing adverse events.
The rigor of the protocol is supported by Mindbloom's published safety data, which shows side effects reported by about 4 to 5% of participants per check-in (sublingual tablets) and 2.8 to 3.2% of participants per check-in (subcutaneous injections), and serious adverse events in fewer than 0.1% of participants.1,8
Ketamine Therapy in Phoenix, Tucson, Scottsdale, and Across Arizona
Mindbloom serves Arizona residents statewide via its telehealth platform, ensuring access to care regardless of geographic location. Because the model is fully remote, there are no geographic restrictions or in-person facility visits required within the state.
- Mindbloom provides guided at-home ketamine therapy to residents in Phoenix, offering an alternative to local IV clinics.
- Clients in Tucson can access the full care model from the comfort of home.
- Residents of Scottsdale receive the same level of provider supervision and guide support.
- The program is also fully available in Mesa, Tempe, Chandler, Gilbert, and Flagstaff.
Importantly, Mindbloom serves residents across rural and suburban Arizona communities through its telehealth platform. You can access advanced mental health care even if you live far from urban medical centers.
Why Choose Mindbloom for Ketamine Therapy in Arizona
Few at-home ketamine providers can point to peer-reviewed outcomes data, a subcutaneous dosing option, and a full integration support model in a single program. Mindbloom brings all three together for eligible adults in Arizona.
Key differentiators include:
- Published research: Mindbloom has published three peer-reviewed studies, the largest published evidence base in at-home ketamine therapy, including a 2022 study of 1,247 clients using sublingual tablets in which 89% reported improvement in depression or anxiety after four sessions.12
- Scale and experience: Mindbloom has completed more than 900,000 sessions, and its 11,441-patient study is the largest published study of at-home ketamine therapy.
- Subcutaneous option: Mindbloom is the only at-home provider offering subcutaneous administration alongside sublingual tablets, which gives clients an alternative to tablets if they prefer injections, want more flexibility, or tried tablets and didn't like them.
- Complete care model: Every program includes medical consults, guide coaching, unlimited Group Integration Circles, unlimited guide messaging, and app-guided programs.
- Affordability: The treatment is approximately 60% more affordable per session than average IV ketamine clinics.
Book My Breakthrough to see if you are a candidate.
How to Choose a Ketamine Therapy Provider in Arizona
Whether considering an in-clinic provider or an at-home program, there are consistent markers of quality care to evaluate. A quality provider should be able to clearly explain their screening process, safety protocols, and integration support.
Questions to ask any prospective provider:
- Medical screening: Does the provider conduct a thorough medical and psychiatric evaluation before prescribing?
- Licensed professionals: Are the prescribing specialists licensed in Arizona with relevant training?
- Treatment protocol: Is there a defined treatment plan with a series of sessions, rather than one-off infusions?
- Integration support: Does the provider offer preparation, coaching, or integration beyond the medication itself?
- Safety protocols: What monitoring is in place during sessions, and what happens if something goes wrong?
- Published outcomes: Has the provider published peer-reviewed research on their specific protocol?
- Transparency: Is pricing clear and upfront, and are eligibility criteria explained before payment?
Watch out for a lack of medical screening, no follow-up care, absence of integration support, hidden pricing, or pressure to commit before an evaluation.
Ketamine Therapy Cost in Arizona
Ketamine therapy costs in Arizona vary significantly based on the modality, the care setting, and what is included in the treatment package. When comparing costs, it is important to consider whether physician supervision, coaching, and integration are bundled into the price.
- IV ketamine infusions: Typically range from $400 to $800+ per session in Arizona clinics. A standard initial series of 4 to 6 sessions can total $2,000 to $5,000+, and is rarely covered by insurance.
- IM ketamine: Costs fall into a similar range as IV infusions, varying by specific facility pricing.
- Spravato (esketamine): May be covered by insurance with prior authorization, though out-of-pocket costs vary widely based on the specific insurance plan and the required in-clinic REMS monitoring.
- At-home ketamine (Mindbloom): Programs are approximately 60% more affordable per session than IV clinics. A 6-session program is $215 per session, billed as $430 per month for 3 months ($1,290 total).
Mindbloom's price includes medical consults, guide coaching, post-session integration, and all session materials. Cost differences are primarily driven by insurance coverage, the number of sessions included, the monitoring model, and whether ongoing support is provided. Mindbloom programs are HSA/FSA eligible, and partial insurance reimbursement may be available.
Important Safety Information
Ketamine is not FDA-approved for PTSD, depression, or anxiety. Common side effects include dissociation, increased blood pressure, nausea, dizziness, and cognitive impairment. Ketamine has abuse potential and is not appropriate for patients with uncontrolled hypertension, psychotic disorders, or substance use disorders. Do not drive or operate machinery until the day after treatment. Individual results may vary. Full safety information: www.mindbloom.com/safety-information
Off-Label Use Disclosure
Ketamine is FDA-approved only as an anesthetic. Use for mental health conditions represents off-label prescribing by licensed clinicians based on clinical judgment. Schedule III Controlled Substance - DEA regulations apply.
Frequently asked questions
Is Mindbloom available in Arizona?
Yes. Mindbloom serves Arizona residents statewide via telehealth, including Phoenix, Tucson, Scottsdale, Mesa, and all other communities across the state. No in-person facility visits are required.
Can ketamine therapy be done at home in Arizona?
Yes, if a licensed physician determines it is medically appropriate after a thorough screening and evaluation. Mindbloom provides a defined treatment framework with medical oversight, a required peer treatment monitor who stays nearby during each session, and thorough integration support.
How quickly does ketamine therapy work and how many sessions are typical?
Many people report noticeable symptom improvement within hours or days of their first session, though more durable benefits typically develop over a series of treatments. Mindbloom offers programs of 6, 12, or 18 sessions, personalized based on your needs and goals.
Is ketamine therapy safe?
A substantial body of peer-reviewed research supports <a href="/blog/is-ketamine-safe-depression-anxiety">ketamine's safety</a> when administered under medical supervision with appropriate screening. In Mindbloom's published studies, side effects were reported by about 4 to 5% of participants per check-in (sublingual tablets) and 2.8 to 3.2% of participants per check-in (subcutaneous injections), with serious adverse events in fewer than 0.1% of participants.
Are ketamine treatments covered by insurance in Arizona?
IV ketamine infusions are rarely covered by insurance, while Spravato (esketamine) may be covered with prior authorization. Mindbloom programs are HSA/FSA eligible, and you can request a superbill to submit for potential partial out-of-network reimbursement.
Do I need a referral for ketamine therapy in Arizona?
Mindbloom begins care with an in-depth medical and psychiatric evaluation by a licensed provider, and a referral from a primary care doctor or therapist is not required to start that process.
What happens during an at-home ketamine session?
You will self-administer the medication in a comfortable setting while your required session monitor remains present. The acute experience lasts about an hour, followed by a post-session window where you will rest and begin your integration practices.

Mindbloom Treatment
See what might be possible with clinician-guided, at-home ketamine therapy. New client programs start at $165 per session.







